CHINA PHARMA HOLDINGS, INC. Shareholders' Equity
CHINA PHARMA HOLDINGS, INC. (CPHI) had Shareholders' Equity of $36.18 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $36.18M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $37.02M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $22.74M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $8.31M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $36.18M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $37.02M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $22.74M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $8.31M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $6.46M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $6.97M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $7.75M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $6.53M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $7.41M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $8.29M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $7.45M 10-K · filed 2026-04-01 | |
| 2023-09-30 | $6.11M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $4.35M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $4.67M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $4.29M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $2.83M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $4.02M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $5.34M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $6.02M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $6.85M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $6.52M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $7.17M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $8.00M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $7.86M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $8.40M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $8.38M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $9.24M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $27.36M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $28.97M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $30.62M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $30.20M 10-K · filed 2021-03-26 | |
| 2018-09-30 | $37.63M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $41.03M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $44.45M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $43.07M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $57.03M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $57.14M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $58.42M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $58.91M 10-K · filed 2019-03-28 | |
| 2016-09-30 | $64.94M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $66.96M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $71.57M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $72.64M 10-K · filed 2018-04-02 | |
| 2015-09-30 | $80.62M 10-Q · filed 2015-12-28 | $86.81M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $86.64M 10-Q · filed 2015-12-28 | $95.00M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $88.46M 10-Q · filed 2015-12-28 | $98.77M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $92.74M 10-K · filed 2016-03-30 | $106.25M 10-K · filed 2015-03-30 |
| 2014-09-30 | $114.66M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $120.95M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $129.44M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $132.94M 10-K · filed 2015-12-28 | |
| 2013-09-30 | $142.86M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $144.28M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $146.52M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $148.52M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $149.33M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $148.16M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $146.21M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $142.48M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $137.63M 10-Q/A · filed 2012-03-06 | $135.92M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $131.04M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $117.94M 10-K · filed 2012-03-14 | |
| 2009-12-31 | $87.87M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |